Online Office System

Journal Online

    column
    Strategy of molecular drug design: dual-target drug design
    GUO Zong-Ru
    2009, 44(3):209-218.
    Abstract PDF
    Small interfering RNA mediated multi-target therapy of cancer
    SHAO Rong-Guang
    2009, 44(3):219-225.
    Abstract PDF
    Multi-target therapeutics and new drug discovery
    XU Tan, Li-Hua-Jun
    2009, 44(3):226-230.
    Abstract PDF
    Controlling arachidonic acid metabolic network: from single- to multi-target inhibitors of key enzymes
    LIU Ying
    2009, 44(3):231-241.
    Abstract PDF
    The signal transduction pathway of multi-target kinase inhibitors as anticancer agents in clinical use or in phase   III
    , , ,
    2009, 44(3):242-257.
    Abstract PDF
    Progress in the research on multi-target-directed drugs against Alzheimer’s disease
    LIU Rui-Ting, Lv-Qiu-Jun
    2009, 44(3):258-263.
    Abstract PDF
    Recent advance in the study of novel anti-tumor targets and drugs —aurora kinase and Pin1
    CHEN Xiao-Guang, Zhang- Yi
    2009, 44(3):264-269.
    Abstract PDF
    Thoughts and experimental exploration on pharmacokinetic study of herbal medicines with multiple-components and targets
    HAO Hai-Beng, Zheng-Chao-Nan, Wang-An-Ji
    2009, 44(3):270-275.
    Abstract PDF
    Design of multiple targeted drugs
    GUO Pan-Shen, Guo-Zong-Ru
    2009, 44(3):276-281.
    Abstract PDF
    The multi-target drugs and their design
    JIANG Feng-Chao
    2009, 44(3):282-287.
    Abstract PDF
    The design, synthesis and anticancer activity of 4-heteroarylamino-3-cyanoquinolines as dual inhibitors of c-Src and iNOS
    CAO Xin, You-Qi-Dong, Li-Zhi-Yu, Guo-Jing-Long, Yang- Yong, Chang- Jing, Yan- Meng, Chen-Ji-Wang, Chen-Meng-Ling
    2009, 44(3):288-295.
    Abstract PDF
    Synergic effects of the combination of VEGF-targeted shRNA and Taxol on human prostate cancer DU145 both in vitro and in vivo
    LI Bao-Wei, Zhang- Min, He-Gong-Wei, Zhang-Qing-Hua, Shao-Rong-Guang
    2009, 44(3):296-302.
    Abstract PDF
    Design, synthesis and 5-HT/NE dual reuptake inhibitory activity of aromatic heterocyclic arylamidine derivatives
    WEN Hui, Yang- Jing, Zhang-Jian-Jun, Wang-E-Fang, Ji-Cheng-Xue, Yang-Guang-Zhong
    2009, 44(3):303-308.
    Abstract PDF
    A novel cell model targeted on GLP-1 receptor for application to anti-diabetic candidates screening
    HUAN Yi, Shen-Zhu-Fang
    2009, 44(3):309-313.
    Abstract PDF
    Comparative pharmacophore analysis of dual dopamine D2/5-HT2A receptor antagonists
    GUO Pan-Shen, Guo-Zong-Ru
    2009, 44(3):314-320.
    Abstract PDF
    Synthesis and cardioprotective effect of a novel anti-ischemic / reperfused injury compound
    LIU Wen-Chong, Sun-Xiao-Chi, Ji-Le-Le, Wang-Hai-Bei, Zhang-Hai-Feng, Li- Jia, Dan- Lei, Jing-Lin-Lin, Gao- Feng
    2009, 44(3):321-326.
    Abstract PDF

    Recommend